{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:16:38Z","timestamp":1790982998211,"version":"4.1.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Neuroendocrine neoplasms (NENs) originate from peptidergic neurons and neuroendocrine cells, possessing endocrine functions, and are commonly found in the gastrointestinal tract, pancreas, and lungs. Neuroendocrine cervix carcinoma (NECC) is infrequent, prone to early dissemination and distant metastasis, and generally has a poor prognosis. The presence of electrolyte imbalance in such cases is even rarer. Here, we present a case of advanced NECC patient who developed refractory hyponatremia, accompanied by severe clinical symptoms such as palpitations, chest tightness, hematemesis, and delirium. Despite extensive investigations, all efforts to elucidate the underlying causes of hyponatremia were negative, suggesting a multifactorial etiology. Next-generation sequencing was also employed to explore the underlying mechanisms at the genetic level. Managing this case posed significant challenges for gynecologic oncologists, as the patient showed minimal response to various treatments, including sodium supplementation, fluid restriction or replenishment, chemotherapy modification, and the use of vasopressin-2 receptor antagonist. This case underscores the importance of monitoring and managing electrolytes in patients with gynecologic NENs, even though the exact mechanisms of such imbalances may remain elusive.<\/jats:p>","DOI":"10.3389\/fendo.2025.1451157","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:39:14Z","timestamp":1740739154000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["An unyielding challenge for refractory hyponatremia in neuroendocrine cervix carcinoma: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Minzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-023-02261-7","article-title":"Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study","volume":"47","author":"Liu","year":"2024","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.3802\/jgo.2023.34.e50","article-title":"RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: a NeCTuR study","volume":"34","author":"Flores Legarreta","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.916506","article-title":"Small Cell (Neuroendocrine) Carcinoma of the Cervix: An Analysis for 19 Cases and Literature Review","volume":"12","author":"Lu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-23-0112","article-title":"Multimodal treatment for resectable neuroendocrine carcinoma of the cervix","volume":"30","author":"Valenza","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-1147","article-title":"A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia","volume":"9","author":"Wu","year":"2020","journal-title":"Trans Lung Cancer Res"},{"key":"B6","article-title":"Cisplatin-induced syndrome of inappropriate antidiuretic hormone (SIADH) in a patient with neuroendocrine tumor of the cervix: a case report and review of the literature","volume":"31","author":"Brown","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"key":"B7","article-title":"Small cell neuroendocrine carcinoma of the uterine cervix presenting with syndrome of inappropriate antidiuretic hormone secretion","volume":"56","author":"Do Young","year":"2013","journal-title":"Obstet Gynecol Sci"},{"key":"B8","article-title":"Rhabdomyolysis in hyponatremia and paraneoplastic syndrome of inappropriate antidiuresis","volume":"34","author":"Elisabetta","year":"2015","journal-title":"Acta Myol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520985657","article-title":"Small cell carcinoma of the cervix complicated by syndrome of inappropriate antidiuretic hormone secretion: a case report","volume":"49","author":"Cai-Fu","year":"2021","journal-title":"J Int Med Res"},{"key":"B10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2466-13-55","article-title":"A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan","volume":"13","author":"Claudia","year":"2013","journal-title":"BMC Pulm Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1382066","article-title":"Case report: Secondary failure to tolvaptan in a patient with SCLC and paraneoplastic SIADH","volume":"15","author":"Menzi","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10388-018-0615-y","article-title":"Hyponatremia in patients with esophageal cancer treated with chemotherapy including cisplatin","volume":"15","author":"Shimada","year":"2018","journal-title":"Esophagus: Off J Japan Esophageal Soc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.47750\/jptcp.2022.907","article-title":"Hyponatremia timing, incidence, and associated risk factors in patients treated with cisplatin for lung cancer: a retrospective study","volume":"29","author":"Ogawa","year":"2022","journal-title":"J Popul Ther Clin Pharmacol = J la Ther Des Popul la Pharmacol Clin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e29592","DOI":"10.1002\/pbc.29592","article-title":"Carboplatin-induced renal salt-wasting syndrome in pediatric patients with intracranial germ cell tumors and concomitant diabetes insipidus","volume":"69","author":"Wan","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.09.012","article-title":"Pituitary Apoplexy-associated Cerebral Salt Wasting Syndrome: A Case Report and Literature Review","volume":"45","author":"Jialu","year":"2023","journal-title":"Clin Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.04.001","article-title":"Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer","volume":"141","author":"Frumovitz","year":"2016","journal-title":"Gynecol Oncol"},{"key":"B17","article-title":"Small-cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: A case report with analysis of molecular abnormalities","volume":"44","author":"Vedran","year":"2023","journal-title":"Neuro Endocrinol Lett"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2321898121","article-title":"Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix","volume":"121","author":"Stefania","year":"2024","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B19","article-title":"Rictor\/mTORC2 is involved in endometrial receptivity by regulating epithelial remodeling","volume":"35","author":"Yue","year":"2021","journal-title":"FASEB J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009111168","article-title":"mTOR complex-2 activates ENaC by phosphorylating SGK1","volume":"21","author":"Ming","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2014.09.024","article-title":"Insulin upregulates the expression of epithelial sodium channel in vitro and in a mouse model of acute lung injury: role of mTORC2\/SGK1 pathway","volume":"331","author":"Jing","year":"2014","journal-title":"Exp Cell Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1451157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:39:18Z","timestamp":1740739158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1451157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":21,"alternative-id":["10.3389\/fendo.2025.1451157"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1451157","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"article-number":"1451157"}}